Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

Me Holding Co.’s stock turned down early Tuesday, after the DNA-testing company reported its latest quarterly loss, shedding ...

Me is to cut 200 jobs in the wake of declining revenues. This company expects a proposed retructuring, affecting 40% of its ...

The once-high-flying firm has been beset by challenges since going public via a SPAC merger in 2021. Here’s the latest.

In this photo illustration, a 23andMe logo seen displayed on a smartphone and in the background. The company announced Monday ...

The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...

The CEO of 23andMe said there was "substantial doubt" that the company could continue to operate and said 40 percent of its ...

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

23andMe, the struggling ancestry tracing company, continues to spiral, raising questions about its business prospects and ...